During the global COVID-19 outbreak, BioEcho developed a rapid extraction protocol that reduced the isolation of SARS-CoV-2-RNA to just a few minutes. Currently, BioEcho offers a CE-marked viral RNA/DNA extraction kit and is implementing automated solutions that will allow customers to increase their diagnostics throughput.
Danish ADCendo ApS will use the funds from a Series A investment to advance Antibody-Drug Conjugates (ADCs) entering cancer cells through endocytic receptors.
The Venture Capital Company Kurma Partners, based in Paris and Munich, appointed Jean-Francois Rivassou as new Partner.
DNA Script will receive a $5m DARPA grant as part of the agency’s Nucleic Acids On-Demand World-Wide Program to prevent the next viral pandemic.
Researchers at Novavax and from the University of Oxford reported an efficacy of 77% of their malaria vaccine, R21/Matrix-M from a Phase II trials in Burkina Faso.
GSK’s and Vir Therapeutics’ COVID-19 antibody treatment VIR-7831 has entered Phase III testing within the UK’s COVID-19 drug testing platform, AGILE
After a positive re-evaluation of J&J’s COVID-19 vaccine by the European Medicines Agency (EMA), J&J has re-started to ship 55 million doses to the EU.
Endeavour Vision has announced the closing of its Heathtech fund Endeavour Medtech Growth II (EMG II) LP at US$375 million in capital commitments.
The Swiss biotech industry experienced a record investment in the pandemic year 2020, according to the new Swiss Biotech Report.
